Ongoing, global campaign focusing on where the registration of diagnostics and direct-acting antivirals has stalled as well as the slow treatment uptake in low- and middle-income countries.
On the occasion of Valentine’s Day, Médecins du Monde and TAG launched actions urging pharma and diagnostics companies to drop their exorbitant prices for latest hep C treatments and tests. More
Less than 5% of people living chronic hepatitis C in LMICs have been diagnosed. We need simpler & cheaper tests to scale up diagnosis! More
An issue brief, developed by Treatment Action Group and Médecins du Monde based on crowdsourced hepatitis C data, providing supplemental evidence on HCV diagnostics availability and pricing. More
Access to Hepatitis C Treatment and Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected
An issue brief, developed by TAG and Médecins du Monde based on crowdsourced hepatitis C data, provides supplemental evidence for advocates on hepatitis C treatment uptake and care among PWID. More
A fact sheet, developed by the hepCoalition, provides in-country data to understand where the branded and generic versions of the HCV cure have been registered and to inform advocacy efforts. More
A fact sheet, developed by the hepCoalition, provides in-country data about HCV treatment rationing through different forms of restrictions. More